Aarti Pharmalabs Limited Share Price & Analysis
₹747▲ +5.34%Updated 1 May 2026, 11:31 am IST
LTP
₹747
+5.34%
Open
₹—
High
₹753.4
Low
₹706.55
Close
₹747
52W High
₹972
52W Low
₹584
Volume
530K
Lot Size
1
Sector
Healthcare
Market Cap
₹7K Cr
Face Value
₹5
Mid Cap
Price Chart
Fundamentals
P/E
31.1
Sector P/E
39.9
P/B
3.31
EPS
₹23.58
ROE
14.5%
ROCE
17.4%
D/E Ratio
0.32
Div Yield
0.68%
Book Value
₹226
+
Strengths
- ✓Efficient capital deployment (ROCE 17.4%)
- ✓Attractively valued vs sector (P/E 31.1x vs industry 39.9x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,808 | ₹4.3L Cr | 35.8 | 5.58 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,503 | ₹1.7L Cr | 68.1 | 11.19 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,185 | ₹1.4L Cr | 61.4 | 16.74 | 26.5 | 27 | 0.33 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,323 | ₹1.1L Cr | 19.8 | 3.06 | 18 | 22.7 | 0.16 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹7,637 | ₹1.1L Cr | 60.5 | 12.08 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,310 | ₹1.1L Cr | 22.2 | 3.21 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,305 | ₹1.1L Cr | 21.2 | 5.36 | 20.6 | 21.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
AARTIPHARM · as of Mar 2026
Promoters44.29%▼0.36
FII7.36%▼1.28
DII7.53%▼2.83
Public40.81%▲4.48
Govt0.01%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 46.46% | 46.46% | 46.46% | 46.10% | 44.65% | 44.29% |
| FII | 8.17% | 8.33% | 7.07% | 7.38% | 8.64% | 7.36% |
| DII | 9.91% | 9.97% | 11.47% | 11.35% | 10.36% | 7.53% |
| Public | 35.45% | 35.24% | 35.00% | 35.17% | 36.33% | 40.81% |
| Govt | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Corporate Events
Interim Dividend - Rs 1.50 Per Share
Dividend15 Feb 2026
Dividend - Rs 2.50 Per Share
Dividend14 Sept 2025
Interim Dividend - Rs 2.50 Per Share
Dividend13 Feb 2025
Dividend - Re 1 Per Share
Dividend30 Jul 2024
Interim Dividend - Rs 2 Per Share
Record: 18 Feb 2024
Dividend15 Feb 2024
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹432 Cr ▲3.3% | ₹418 Cr ▲8.3% | ₹386 Cr ▼31.6% | ₹564 Cr ▲4.8% | ₹538 Cr ▲17.5% | ₹458 Cr ▼17.5% | ₹555 Cr ▲9.7% | ₹506 Cr |
| Op. Profit | ₹102 Cr ▲37.8% | ₹74 Cr ▼20.4% | ₹93 Cr ▼36.3% | ₹146 Cr ▲13.2% | ₹129 Cr ▲37.2% | ₹94 Cr ▼2.1% | ₹96 Cr ▼18.6% | ₹118 Cr |
| OPM | 24.0% ▲33.3% | 18.0% ▼25.0% | 24.0% ▼7.7% | 26.0% ▲8.3% | 24.0% ▲20.0% | 20.0% ▲17.6% | 17.0% ▼26.1% | 23.0% |
| Net Profit | ₹48 Cr ▲71.4% | ₹28 Cr ▼44.0% | ₹50 Cr ▼43.2% | ₹88 Cr ▲18.9% | ₹74 Cr ▲34.5% | ₹55 Cr ▲0.0% | ₹55 Cr ▼15.4% | ₹65 Cr |
| EPS (₹) | 5.29 ▲71.8% | 3.08 ▼43.6% | 5.46 ▼44.0% | 9.75 ▲19.5% | 8.16 ▲35.3% | 6.03 ▼1.5% | 6.12 ▼15.0% | 7.2 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Revenue | ₹2.1K Cr ▲14.1% | ₹1.9K Cr ▼4.7% | ₹1.9K Cr ▲62.1% | ₹1.2K Cr | ₹0 Cr |
| Expenses | ₹1.7K Cr ▲12.5% | ₹1.5K Cr ▼8.5% | ₹1.6K Cr ▲61.4% | ₹993 Cr | ₹0 Cr |
| Op. Profit | ₹464 Cr ▲20.2% | ₹386 Cr ▲12.9% | ₹342 Cr ▲65.2% | ₹207 Cr | ₹0 Cr |
| OPM | 22.0% ▲4.8% | 21.0% ▲16.7% | 18.0% ▲5.9% | 17.0% | — |
| Other Income | ₹10 Cr ▲100.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▼33.3% | ₹3 Cr | ₹0 Cr |
| Interest | ₹27 Cr ▲58.8% | ₹17 Cr ▼19.0% | ₹21 Cr ▲75.0% | ₹12 Cr | ₹0 Cr |
| Depreciation | ₹87 Cr ▲19.2% | ₹73 Cr ▲15.9% | ₹63 Cr ▲50.0% | ₹42 Cr | ₹0 Cr |
| PBT | ₹361 Cr ▲20.3% | ₹300 Cr ▲14.9% | ₹261 Cr ▲68.4% | ₹155 Cr | ₹0 Cr |
| Tax % | 24.0% ▼14.3% | 28.0% ▲7.7% | 26.0% ▲23.8% | 21.0% | — |
| Net Profit | ₹272 Cr ▲25.3% | ₹217 Cr ▲12.4% | ₹193 Cr ▲58.2% | ₹122 Cr | ₹0 Cr |
| EPS (₹) | 30.05 ▲25.6% | 23.93 ▲12.1% | 21.35 | — | — |
| Div Payout | 17.0% ▲30.8% | 13.0% ▲44.4% | 9.0% | 0.0% | — |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Liabilities | ||||||
| Equity Capital | ₹45 Cr ▲0.0% | ₹45 Cr ▲0.0% | ₹45 Cr ▲0.0% | ₹45 Cr ▲17900.0% | ₹0.25 Cr ▲0.0% | ₹0.25 Cr |
| Reserves | ₹2.0K Cr ▲2.9% | ₹1.9K Cr ▲13.6% | ₹1.7K Cr ▲13.2% | ₹1.5K Cr ▲9.2% | ₹1.4K Cr | ₹0 Cr |
| Borrowings | ₹659 Cr ▲59.6% | ₹413 Cr ▲44.9% | ₹285 Cr ▲32.6% | ₹215 Cr ▼37.0% | ₹341 Cr | ₹0 Cr |
| Other Liabilities | ₹561 Cr ▲11.5% | ₹503 Cr ▼6.9% | ₹540 Cr ▲14.9% | ₹470 Cr ▲50.6% | ₹312 Cr | ₹0 Cr |
| Total Liabilities | ₹3.3K Cr ▲12.4% | ₹2.9K Cr ▲12.5% | ₹2.6K Cr ▲15.1% | ₹2.2K Cr ▲10.0% | ₹2.0K Cr | ₹0 Cr |
| Assets | ||||||
| Fixed Assets | ₹1.5K Cr ▲33.2% | ₹1.1K Cr ▲10.1% | ₹1.0K Cr ▲11.6% | ₹926 Cr ▲18.4% | ₹782 Cr | ₹0 Cr |
| CWIP | ₹160 Cr ▼57.2% | ₹374 Cr ▲173.0% | ₹137 Cr ▲34.3% | ₹102 Cr ▼45.5% | ₹187 Cr | ₹0 Cr |
| Investments | ₹187 Cr ▲142.9% | ₹77 Cr ▼28.0% | ₹107 Cr ▲23.0% | ₹87 Cr ▲171.9% | ₹32 Cr | ₹0 Cr |
| Other Assets | ₹1.4K Cr ▲6.4% | ₹1.3K Cr ▲1.1% | ₹1.3K Cr ▲15.5% | ₹1.1K Cr ▲8.9% | ₹1.0K Cr | ₹0 Cr |
| Total Assets | ₹3.3K Cr ▲12.4% | ₹2.9K Cr ▲12.5% | ₹2.6K Cr ▲15.1% | ₹2.2K Cr ▲10.0% | ₹2.0K Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Operating CF | ₹332 Cr ▲53.7% | ₹216 Cr ▼13.6% | ₹250 Cr ▲668.2% | ₹-44 Cr | ₹0 Cr |
| Investing CF | ₹-414 Cr ▼92.6% | ₹-215 Cr ▼36.1% | ₹-158 Cr ▼13.7% | ₹-139 Cr | ₹0 Cr |
| Financing CF | ₹65 Cr ▲550.0% | ₹10 Cr ▲106.1% | ₹-163 Cr ▼162.7% | ₹260 Cr | ₹0 Cr |
| Net Cash Flow | ₹-17 Cr ▼241.7% | ₹12 Cr ▲116.9% | ₹-71 Cr ▼191.0% | ₹78 Cr | ₹0 Cr |
| Free Cash Flow | ₹-112 Cr ▼722.2% | ₹18 Cr ▼86.2% | ₹130 Cr ▲170.3% | ₹-185 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Debtor Days | 99d ▼2.9% | 102d ▲21.4% | 84d ▼27.0% | 115d | — |
| Inventory Days | 190d ▼17.4% | 230d ▲22.3% | 188d ▼30.9% | 272d | — |
| Days Payable | 90d ▼33.3% | 135d ▲27.4% | 106d ▼13.8% | 123d | — |
| Cash Conv. Cycle | 200d ▲1.5% | 197d ▲18.7% | 166d ▼37.1% | 264d | — |
| Working Capital Days | 105d ▼4.5% | 110d ▲17.0% | 94d ▼15.3% | 111d | — |
| ROCE | 17.0% ▲0.0% | 17.0% ▲6.3% | 16.0% ▼15.8% | 19.0% | — |
Source: Screener.in · Lower days = better efficiency
About Aarti Pharmalabs Limited
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Aarti Pharmalabs Limited share price today?▾
Aarti Pharmalabs Limited (AARTIPHARM) is currently trading at ₹747 on NSE, up 5.34% as of the last market session. Prices update daily after market close on MarketNetra.
Is Aarti Pharmalabs Limited available in F&O (Futures & Options)?▾
Yes, Aarti Pharmalabs Limited (AARTIPHARM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Aarti Pharmalabs Limited 52-week high and low?▾
Aarti Pharmalabs Limited's 52-week high is ₹972 and the 52-week low is ₹584. The current price of ₹747 is 23.1% below the 52W high.
What is Aarti Pharmalabs Limited P/E ratio?▾
Aarti Pharmalabs Limited's current P/E ratio is 31.1. This indicates the market is paying ₹31.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Aarti Pharmalabs Limited options?▾
Aarti Pharmalabs Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade AARTIPHARM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.